Ansa Biotechnologies

Berkeley, CA

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

https://ansabio.com/

Claim this profile

Employbl Premium

Get the inside track on Ansa Biotechnologies

Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.

AI chat about Ansa Biotechnologies's culture, stack, and interview process
Save jobs and get alerts on new openings
Full premium profiles across our company index
7-day free trial, then $25/mo. Cancel anytime.

Start free trial →Already have an account? Sign in

Company Details

Founded: 2018
Employees: Between 10 - 100 employees
Raised: $83,419,680
Headquarters Location: Berkeley, CA
Public: No
Acquired: No
CEO: Jason T. Gammack
Founders: Daniel Lin-Arlow
Sebastian Palluk
Jared Ellefson

Company Collections

These are collections Ansa Biotechnologies is a part of. Click on the collection name to view similar companies.

Ansa Biotechnologies' Investors

Ansa Biotechnologies' Industries

Software Companies

Medical Organizations

Biotechnology Companies

Ansa Biotechnologies' Tech Stack

Current Job Listings

Listing 0 of 7 job openings

Ansa Biotechnologies Headquarters Location

626 Bancroft Wy suite a, Berkeley, CA, 94710

Loading map…

Total Amount Raised: $83,419,680

Ansa Biotechnologies' Investors

Ansa Biotechnologies Funding Rounds

Series B
$46,449,665
Oct 1, 2025
Series A
$68,000,000
Apr 11, 2022
Series A
$68,000,000
Apr 10, 2022
Series A Investors
Northpond Ventures
Codon Capital
Blue Water Life Science Fund
Carbon Silicon Ventures
Mubadala Capital Ventures
Horizons Ventures
Fiscus Ventures
Altitude Life Science Ventures
PEAK6
Fifty Years
RA Capital Management
Humboldt Fund
Mei Z.
Series Unknown
$5,000,000
Oct 15, 2021
Series Unknown
$5,000,000
Oct 14, 2021
Series Unknown Investors
Horizons Ventures
Humboldt Fund
Mubadala Capital Ventures
Grant
$994,682
Apr 9, 2021
Grant
$994,682
Apr 8, 2021
Grant Investors
National Science Foundation (NSF)
Seed
$7,900,000
Jun 24, 2020
Seed
$7,900,000
Jun 23, 2020
Seed Investors
Horizons Ventures
Mubadala Capital Ventures
Humboldt Fund
Y Combinator
Grant
$225,000
Jun 19, 2019
Grant
$225,000
Jun 18, 2019
Grant Investors
National Science Foundation (NSF)
Pre Seed
$1,300,000
Dec 1, 2018
Pre Seed
$1,300,000
Nov 30, 2018
Pre Seed Investors
Fifty Years

Funding info provided by Diffbot.

Ansa Biotechnologies Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ansa Biotechnologies.